This trial is conducted in the United States of America (USA). The purpose of this study is to compare the effectiveness and safety of a biphasic insulin aspart standard titration regimen when coupled with dietary intervention to standard titration without dietary intervention.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
4,877
Novo Nordisk Clinical Trial Call Center
Princeton, New Jersey, United States
HbA1c and Incidence of hypoglycemia
Time frame: After 24 weeks of treatment
Postprandial glucose from 8-point SMBG spontaneously reported adverse events; any changes from baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.